Lv64
2350 积分 2025-03-17 加入
Efficacy and Safety of Switching to Picankibart from Non-interleukin-23 Subunit p19 Inhibitors in Patients with Plaque Psoriasis: A Multicenter, Open-Label, Phase 2 Trial
2个月前
已完结
Current and future landscape of Bruton tyrosine kinase inhibitors in allergy
2个月前
已关闭
Emerging drugs for the treatment of bullous pemphigoid: what’s new on the horizon?
2个月前
已完结
Dupilumab significantly improves itch and hives in patients with chronic spontaneous urticaria (CUPID study C)
4个月前
已完结
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial
6个月前
已完结
Consider approved biologics and be aware of emerging agents in hidradenitis suppurativa
8个月前
已完结
苈白泄肺平喘汤治疗小儿肺炎支原体感染后慢性咳嗽的效果观察
皖公网安备34019202002308
